AGP Executive Report
Last update: 3 hours agoObesity Research: Roche will pay up to $1.16 billion for rights to a Chinese biotech’s experimental RNAi drug, targeting a pathway that may reduce fat while preserving muscle. Swiss Science: University of Geneva researchers found that switching to an all-plant-protein diet quickly changed liver metabolism in mice and reduced their willingness to exercise. Quantum Technology: Infineon and Swiss startup ZuriQ are expanding work on scalable trapped-ion quantum chips. Cybersecurity: Geneva-based SEALSQ presented research showing how side-channel leakage could expose secrets during ML-KEM key generation, highlighting security challenges for post-quantum cryptography. Virology: The Geneva Centre for Emerging Viral Diseases has joined the Global Virus Network, adding Swiss expertise in emerging infections, vaccines and surveillance to its international network.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
